FDA Class II · Drug · October 14, 2026
Biospectra Tris/Tromethamine recall — BioSpectra, Inc.
Failed stability specifications
Official ID D-0012-2027 · Official record ↗
Recall found. BioSpectra is named in FDA Class II recall D-0012-2027 covering Biospectra Tris/Tromethamine. Hazard: Failed stability specifications Identifying details: Lot#: TRIS -E04-0226-0016; Exp 2/29/28. Status: Ongoing.
Failed stability specifications
Official ID D-0012-2027 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 12:00 PM UTC.